Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study

2021

Stein, Eytan M.

DiNardo, Courtney D.

Fathi, Amir T.

Mims, Alice S.

Pratz, Keith W.

et al.

Wissenschaftlicher Artikel

Blood ; 137 (2021), 13. - S. 1792-1803. - ISSN 0006-4971. - eISSN 1528-0020

UKU. Klinik für Innere Medizin III

[Free subject headings]: ACUTE MYELOID-LEUKEMIA | MUTATIONS | OLDER | AGE
[DDC subject group]: DDC 610 / Medicine & health